1.32
1.49%
-0.02
Passage Bio Inc (PASG) 最新ニュース
Biopharma Layoff Tracker 2024: Erasca, Bolt, Tenaya and More Cut Staff - BioSpace
BioSpace
Biopharma Layoff Tracker 2024: Erasca, Bolt, Tenaya and More Cut Staff - BioSpace
BioSpace
Biopharma Layoff Tracker 2024: Erasca, Bolt, Tenaya and More Cut Staff - BioSpace
BioSpace
Biopharma Layoff Tracker 2024: Erasca, Bolt, Tenaya and More Cut Staff - BioSpace
BioSpace
Wedbush Weighs in on Passage Bio, Inc.'s Q2 2024 Earnings (NASDAQ:PASG) - MarketBeat
MarketBeat
All You Need to Know About Passage Bio (PASG) Rating Upgrade to Buy - Yahoo Finance UK
Yahoo Finance UK
Passage Bio, Inc. (NASDAQ:PASG) to Post Q2 2024 Earnings of ($0.29) Per Share, Wedbush Forecasts - Defense World
Defense World
Passage Bio Reports Promising Interim Data in FTD-GRN Treatment Trial - MyChesCo
MyChesCo
Passage Bio (NASDAQ:PASG) Price Target Cut to $13.00 by Analysts at Canaccord Genuity Group - MarketBeat
MarketBeat
Equities Analysts Issue Forecasts for Passage Bio, Inc.'s Q1 2025 Earnings (NASDAQ:PASG) - MarketBeat
MarketBeat
Biopharma Layoff Tracker 2024: Bolt, Tenaya, BioMarin and More Cut Staff - BioSpace
BioSpace
Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights - Yahoo Finance
Yahoo Finance
Passage Bio (NASDAQ:PASG) Shares Up 0.7% - MarketBeat
MarketBeat
Recent Insider Activity Suggests Potential Gains for Passage Bio Inc (PASG) – Knox Daily - Knox Daily
Knox Daily
Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
GlobeNewswire Inc.
Passage Bio to Present at Chardan's 8th Annual Genetic - GlobeNewswire
GlobeNewswire
Smartphone Tests Detect Frontotemporal Dementia - Medpage Today
Medpage Today
Leadership | BioMarin - Investor Relations : BioMarin
Investor Relations : BioMarin
Passage Bio, Inc. (PASG) Is Up 24.26% in One Week: What You Should Know - Yahoo Finance
Yahoo Finance
Passage Bio Seeks Pennsylvania College Student Candidates for Third Annual Tachi Yamada Scholarship Program - BioBuzz
BioBuzz
Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights
GlobeNewswire Inc.
Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights - Yahoo Finance
Yahoo Finance
Passage Bio to Participate in Upcoming Investor Conferences
GlobeNewswire Inc.
Gene and Cell Therapies Targeting CNS Disorders Market is Predicted to Exhibit Remarkable Growth by 2032 ... - GlobeNewswire
GlobeNewswire
Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
GlobeNewswire Inc.
Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference - GlobeNewswire
GlobeNewswire
Why BlackBerry Shares Are Trading Lower By Over 5%; Here Are 20 Stocks Moving Premarket
Benzinga
Passage Bio reports data from FTD-GRN gene therapy trial - Clinical Trials Arena
Clinical Trials Arena
Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic Priorities
GlobeNewswire Inc.
Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated ... - GlobeNewswire
GlobeNewswire
Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights - Yahoo Finance
Yahoo Finance
Frontotemporal Dementia Treatment Drug Market to Showcase Immense Growth During the Study Period (2019–2032 ... - GlobeNewswire
GlobeNewswire
Dementia Market to Grow Rapidly, Estimates DelveInsight | Key Companies Active in the Market - Pfizer, Eli Lilly and ... - PR Newswire
PR Newswire
Ann Lee-Karlon named CEO of EpiBiologics - BioCentury
BioCentury
30+ Best Stocks Under $2 to Invest in 2023 - Stocks Telegraph
Stocks Telegraph
Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Yahoo
Yahoo
Passage Bio Seeks Pennsylvania College Student Candidates for Second Annual Tachi Yamada Scholarship Program - Yahoo
Yahoo
Passage Bio to Present at Cowen 43rd Annual Health Care Conference - Yahoo
Yahoo
Passage Bio Presents Additional Interim Data from Imagine-1 Study for GM1 Gangliosidosis at 19th Annual ... - MyChesCo
MyChesCo
Rough Passage: Gene Therapy Developer Hunkers Down after Job, Pipeline Cuts - Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News
Fierce Biotech Layoff Tracker: Layoffs strike 119 companies in 2022 - Fierce Biotech
Fierce Biotech
Thomas Woiwode Net Worth (2024) - GuruFocus.com
GuruFocus.com
Movers & Shakers: CEO Shakeups at BIO, Passage Bio and Palisade Bio - BioSpace
BioSpace
Power Moves: Burro hired its new VP of engineering from Toyota Research Institute - Technical.ly
Technical.ly
Passage Bio Appoints William Chou CEO - citybiz
citybiz
Passage Bio and CEO Bruce Goldsmith part ways - Philadelphia Business Journal - The Business Journals
The Business Journals
Five Philly Gene Therapy Companies You Should Know - BioBuzz
BioBuzz
Leaked reports allege that Penn officials led 'shameless cover-up' to protect Gene Therapy Program - The Daily Pennsylvanian
The Daily Pennsylvanian
Frontotemporal Dementia Pipeline Landscape Analysis of 20+ Companies by DelveInsight - GlobeNewswire
GlobeNewswire
Investors Eye Gene Therapy Companies and Rapidly Expanding Market - BioBuzz
BioBuzz
大文字化:
|
ボリューム (24 時間):